Company intelligence / Profile preview

Transnational Cannabis Ltd. (formerly ICC International Cannabis Corp.)

Toronto, Ontario, Canada

Ownership: Private
Employees: ~3
Development stage: Other

Overview

The company focused on becoming a leading pharmaceutical-grade producer of cannabidiol (CBD) and other cannabinoid extracts. It operated as a fully licensed producer in Uruguay with plans to produce medicinal cannabis products including CBD oil branded as "BIDIOL" and other pharmaceutical formulations.

Therapeutic areas: Other
Modalities: Cannabinoid extraction and formulationSmall molecule (cannabinoid-based products)
Industry: Biotech

Partnerships

Wayland Group (49.9% sale of international business agreement)

Beyond the preview

Go deeper on Transnational Cannabis Ltd. (formerly ICC International Cannabis Corp.).

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transnational Cannabis Ltd. (formerly ICC International Cannabis Corp.).

Explore the full profile